Regardless of outward dynamics, healthcare is one of life's necessities. It is inspiring to work alongside these businesses as they look to grow and develop and continue to support our community.
Hannah provides mergers and acquisitions (M&A) advisory services as a member of Lincoln’s Global Healthcare Group. She has executed both sell-side and buy-side M&A transactions for a range of private equity-owned and public clients, and in previous roles completed two of the largest initial public offerings on the Australian Securities Exchange and restructured a number of portfolio companies of large multinational private equity clients in Australia. Hannah’s experience spans domestic and international markets, having advised clients based in the U.S., U.K., New Zealand, Australia and parts of Asia.
Hannah applies her deep healthcare expertise to help clients with transactional opportunities as a result of positive macro trends in the industry. By running bespoke, competitive global processes with her full focus on all facets of a transaction, Hannah ensures an optimal outcome for her clients.
Prior to joining Lincoln, Hannah worked in the healthcare M&A team at KPMG. Previously, she worked in the special situations team of Moelis & Company in Sydney, focused primarily on capital restructures, capital amendments and equity conversions. Hannah started her career in the equity capital markets team at Credit Suisse.
Hannah earned a Bachelor of Laws and a Bachelor of Commerce from the University of Newcastle, Australia.
Recent Transactions in Healthcare
Lincoln International is pleased to announce that it advised Brenntag AG in the sale of Biosector A/S to British specialty chemicals company Croda International plc for a total consideration of Euro 72 million
Lincoln’s Healthcare and TMT groups team to create outlier result for leading Healthcare IT platform
Lincoln International represents Path-Tec, a portfolio company of Fulcrum Equity Partners, in its sale to Lab Logistics, a portfolio company of Atlantic Street Capital
Lincoln International is pleased to announce the sale of BioAgilytix, a portfolio company of Riverside Partners, to Cobepa S.A.
Lincoln International advised Advanced Instruments on a distribution agreement for GloCyte
Lincoln International represents Vancoppenolle Moreau Company in its sale to WebMD a portfolio company of KKR